PASW Financials

Evaluating the bottom line, Ping An Biomedical Co Ltd maintains a gross margin of 2.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -43.05%, while the net margin is -37.57%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively PASW converts its operational activities into shareholder value.